MedTrace Logo

Mindful Breaths: Mindfulness for Young Adult Vaping

NCT06626529 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-07-23

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the feasibility, acceptability, and preliminary efficacy of mindfulness-based interventions (MBI) as a vaping cessation intervention in young adults aged 18-29 who vape nicotine at least 25 days per month and are interested in cutting down or quitting. The main questions it aims to answer are:

* Can mindfulness practice reduce nicotine cravings in young adults?
* Is mindfulness practice an acceptable and feasible intervention for vaping cessation in this population?

Researchers will compare participants in the mindfulness intervention group to a control group that watches a video with calming music and images to see if mindfulness practice has a greater effect on reducing nicotine cravings.

Participants will:

* Complete a baseline survey and craving cue reactivity assessment.
* Engage in a 10-minute guided mindfulness meditation (intervention group) or view calming music and images (control group).
* Rate their cravings and the acceptability, appropriateness, and feasibility of the intervention after the session.

Conditions

  • Vaping Cessation

Interventions

BEHAVIORAL

Guided mindfulness meditation

Watching a video of a guided mindfulness meditation include paying attention to the breath, promoting natural breathing without force; body scan, directing awareness from the head down to the toes, allowing tension to release in each area. The intervention emphasizes observing sensations without judgment, fostering a state of relaxed awareness.

BEHAVIORAL

Scenery video

Watching a ten-minute video of calming music and images

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06626529 on ClinicalTrials.gov